Human Hypertension Lung Endothelial Cells
Quick Actions
Product Overview
Description
Pulmonary hypertension (PH) is a devastating and progressive cardiopulmonary disease defined by a sustained elevation in mean pulmonary arterial pressure exceeding 20 mmHg at rest, as measured by right heart catheterization. At the very center of this disease’s origin and progression lies a population of highly specialized cells lining the inner walls of the lung’s blood vessels the lung endothelial cells (ECs). These cells are not passive bystanders; they are dynamic, metabolically active regulators of vascular biology.
When they malfunction, the consequences cascade into irreversible structural changes that ultimately threaten the patient’s life.
Guarantee expansion for a minimum of 2-5 population
doublings.
IMPORTANT: Quality warranty requires use of NeoBioPharma media. Biohazardous material despite negative pathogen testing. Quality claims must be reported within 1 month.
Key Features
Catalog Number: NBPH005
Product Format: Frozen
Vial Cell Number: > 5x10[5] cells/vial
Passage:1(P1)
Storage: Liquid Nitrogen, Vapor Phase
Intended Use: Research use only (RUO)
Characterization Markers
Positive for endothelial markers: for Acetylated LDL (DiI-Ac-
LDL) uptake and Factor VIII-related antigen / CD31 expression
Quick Facts
Product Type
Human Hypertension Cells
Viability
>85% viable (Post-thaw)
Applications
Research & Development
Availability
In Stock • Global Shipping
Technical Specifications
Applications & Use Cases
Research Areas
In Vitro Studies
Cell culture and screening applications
Molecular Biology
Gene expression & signaling studies
Drug Discovery
Screening & validation studies
Disease Modeling
Pathophysiology research
Support & Resources
Technical Support
Our experts are available for technical questions and protocol assistance.
Contact Support
